Boceprevir
Janessa Smith, Pharm.D. BCPS, Paul A. Pham, PharmD
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Boceprevir is indicated for the treatment of HCV (genotype1, used in combination with peg-INF + ribavirin) in adult patients with compensated liver disease, including cirrhosis.
- Boceprevir may be used in either treatment-naïve patients or those who have failed previously interferon/ribavirin therapy.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved